A Double-blind, Placebo-controlled, Parallel-group Study to Determine the Effect of BRL- 49653C Rosiglitazone, on Fat Distribution When Administered for 26 Weeks to Subjects With Impaired Glucose Tole...

Mise à jour : Il y a 4 ans
Référence : GSK49653/131

A Double-blind, Placebo-controlled, Parallel-group Study to Determine the Effect of BRL- 49653C Rosiglitazone, on Fat Distribution When Administered for 26 Weeks to Subjects With Impaired Glucose Tolerance (IGT)

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait


Liens